Epithelial dysfunction is prevented by IL-22 treatment in a <i>Citrobacter rodentium</i>-induced colitis model that shares similarities with inflammatory bowel disease
2022-11-13
Qifan Zhu, Daniel Korenfeld, Abel Suarez-Fueyo, Sean Graham, Liang Jin, Shivesh Punit, Rachael Duffy, Munish Puri, Andrew Caruso, Chenqi Hu, Yu Tian, Bradford L. McRae, Raj Kamath, Lucy Phillips, Annette J. Schwartz-Sterman, Susan Westmoreland, Xiaohong Cao, Marc C. Levesque, Yingtao Bi, Jesus Paez-Cortez, Radhika Goenka
Mucosal Immunology, Published online: 13 November 2022; doi:10.1038/s41385-022-00577-w Epithelial dysfunction is prevented by IL-22 treatment in a Citrobacter rodentium -induced colitis model that shares similarities with inflammatory bowel disease